Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D and its molecular correlation Topic | Key findings | Mechanisms | Clinical insights | Research gaps | References: Tumor-Specific Effects |: Vitamin D deficiency in up to 87.6% of GI cancer patients. |: Regulates proliferation, differentiation, apoptosis, and gut homeostasis.: Inhibits cancer stem cells. |: Supplementation reduced deficiency from 91.3% to 57.6%.: Shows promise in GI cancers (e.g., colorectal). |: Requires further studies to validate its role in prevention and treatment.: Long-term impact of supplementation remains unclear. | [16,18,49,55]

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Narrative review.

Narrative review

Discusses existing research; systematic-review methods have not been established by this classification.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The role of vitamin D in gastrointestinal cancer prevention and management: a narrative review

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The role of vitamin D in gastrointestinal cancer prevention and management: a narrative review

Narrative review · Annals of Medicine and Surgery · 2025

Original publication title

The role of vitamin D in gastrointestinal cancer prevention and management: a narrative review

Nasar Nasrullah Khan; Tusneem Shehzadi; Zim Warda Hasan; Ariana Panezai; Muhammad Naqash; Asad Ur Rehman; Anmol Mohan; Dev Tanush; Hasiba Karimi; Hasibullah Aminpoor; Usha Tejwaney; Sarwan Kumar

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Gastrointestinal (GI) cancers, including colorectal, gastric, esophageal, pancreatic, and liver cancers, represent a significant global health burden, with high prevalence and mortality rates driven by aging, lifestyle factors, and infections. Emerging research highlights the role of vitamin D in cancer biology, particularly its potential in the prevention and management of GI cancers. Through its active form, calcitriol, vitamin D regulates cell proliferation, apoptosis, angiogenesis, and immune responses via the vitamin D receptor (VDR). Epidemiological studies suggest an inverse association between vitamin D deficiency and cancer risk, while experimental models demonstrate its anti-tumor effects.

Additionally, vitamin D influences gut microbiota composition and immune regulation, potentially enhancing cancer immunity and response to immunotherapy. Despite promising evidence, clinical trials have yielded mixed results, underscoring the need for further research to determine optimal supplementation strategies, individual responses, and genetic influences. This review explores vitamin D’s mechanisms, epidemiological evidence, and therapeutic potential in GI cancers, advocating for personalized approaches in cancer prevention and treatment.

Authors’ abstract

Gastrointestinal (GI) cancers, including colorectal, gastric, esophageal, pancreatic, and liver cancers, represent a significant global health burden, with high prevalence and mortality rates driven by aging, lifestyle factors, and infections. Emerging research highlights the role of vitamin D in cancer biology, particularly its potential in the prevention and management of GI cancers. Through its active form, calcitriol, vitamin D regulates cell proliferation, apoptosis, angiogenesis, and immune responses via the vitamin D receptor (VDR). Epidemiological studies suggest an inverse association between vitamin D deficiency and cancer risk, while experimental models demonstrate its anti-tumor effects.

Additionally, vitamin D influences gut microbiota composition and immune regulation, potentially enhancing cancer immunity and response to immunotherapy. Despite promising evidence, clinical trials have yielded mixed results, underscoring the need for further research to determine optimal supplementation strategies, individual responses, and genetic influences. This review explores vitamin D’s mechanisms, epidemiological evidence, and therapeutic potential in GI cancers, advocating for personalized approaches in cancer prevention and treatment.

Publication and source details

Original title: The role of vitamin D in gastrointestinal cancer prevention and management: a narrative review

Nasar Nasrullah Khan; Tusneem Shehzadi; Zim Warda Hasan; Ariana Panezai; Muhammad Naqash; Asad Ur Rehman; Anmol Mohan; Dev Tanush; Hasiba Karimi; Hasibullah Aminpoor; Usha Tejwaney; Sarwan Kumar

Annals of Medicine and Surgery · 2025

* Corresponding author. Address: Kabul University of Medical Sciences “Abu Ali Ibn Sina “, Ata Turk Avenue, Jamal Mena, 3rd District, Kabul 1001, Afghanistan. Tel.: +93730097097. E-mail: hasibaminpoor786@gmail.com (H. Aminpoor).Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:41:52.712283+00:00

DOI: 10.1097/ms9.0000000000004114 · PMC12688799